Scancell Holdings PLC (SCLP)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

9.00p

Buy

10.00p

arrow-down-0.25p (-2.56%)

Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.
Prices updated at 29 May 2025, 15:54 BST
| Prices minimum 15 mins delay
|
Prices in GBX
10.00p - 9.50p
19.75p - 7.26p
-
101.09m
-
30,000
160,390
-
896,234.53
1.42
928.98m
GB00B63D3314
-0.02
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.